HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection

Salim I. Khakoo, Chloe L. Thio, Maureen P. Martin, Collin R. Brooks, Xiaojiang Gao, Jacquie Astemborski, Jie Cheng, James J. Goedert, David Vlahov, Margaret Hilgartner, Steven Cox, Ann Margeret Little, Graeme J. Alexander, Matthew E. Cramp, Stephen J. O'Brien, William M.C. Rosenberg, David L. Thomas, Mary Carrington

Research output: Contribution to journalArticlepeer-review

Abstract

Natural killer (NK) cells provide a central defense against viral infection by using inhibitory and activation receptors for major histocompatibility complex class I molecules as a means of controlling their activity. We show that genes encoding the inhibitory NK cell receptor KIR2DL3 and its human leukocyte antigen C group 1 (HLA-C1) ligand directly influence resolution of hepatitis C virus (HCV) infection. This effect was observed in Caucasians and African Americans with expected low infectious doses of HCV but not in those with high-dose exposure, in whom the innate immune response is likely overwhelmed. The data strongly suggest that inhibitory NK cell interactions are important in determining antiviral immunity and that diminished inhibitory responses confer protection against HCV.

Original languageEnglish (US)
Pages (from-to)872-874
Number of pages3
JournalScience
Volume305
Issue number5685
DOIs
StatePublished - Aug 6 2004

ASJC Scopus subject areas

  • General

Fingerprint

Dive into the research topics of 'HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection'. Together they form a unique fingerprint.

Cite this